MTA-100 Thermal Ablation System

Description

In 2019, WHO issued new guidelines for the use of thermal ablation for cervical pre-cancerous lesions. While they continue to recommend cryotherapy, the WHO has offered thermal ablation as an alternative method of treatment for specific environments. is pleased to announce its latest device: MTA-100 Thermal Ablation System. The device is a portable, lightweight device for the treatment of pre-cancerous lesions optimized for 20, 40, or 60 second intervals of treatment.

Product Features

  • Optimized to offer 20, 40, or 60 second internals for procedure
  • Bright LED lights for clear viewing of cervical area
  • Digital display to detailing temperature at all stages of procedure
  • Durable and ergonomic handle for ease of use
  • 25mm tip available offering larger treatment area (5 types of interchangeable gold alloy tips)
  • Sound and light activation for beginning and end of procedure
  • Sterilized protective cover included
  • Patented
Category: